Journal of Pharmaceutical Policy and Practice
[Accessed 15 Jun 2019]
| 11 June 2019
Pharmacovigilance systems in resource-limited settings: an evaluative case study of Sierra Leone
Few low and middle-income countries (LMIC) have fully operational pharmacovigilance structures, systems and legal framework to collect and collate safety data and evaluate the risks and benefits by active and passive approaches. However, in a LMIC such as Sierra Leone, the capacity to manage the risks by taking appropriate preventative actions to help inform therapeutic decisions, promote rational use of medicines, guide risk management and communications is gradually growing but yet to be fully optimized. This study sought to assess the current status of pharmacovigilance in Sierra Leone since it became the 87th member of the World Health Organisation International Drug Monitoring Programme.
Authors: Onome T. Abiri and Wiltshire C. N. Johnson